279 related articles for article (PubMed ID: 27993972)
1. Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia.
Nandakumar V; Hebrink D; Jenson P; Kottom T; Limper AH
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 27993972
[TBL] [Abstract][Full Text] [Related]
2. A critical role for CARD9 in pneumocystis pneumonia host defence.
Kottom TJ; Nandakumar V; Hebrink DM; Carmona EM; Limper AH
Cell Microbiol; 2020 Oct; 22(10):e13235. PubMed ID: 32548948
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
Fraser IP; Takahashi K; Koziel H; Fardin B; Harmsen A; Ezekowitz RA
Microbes Infect; 2000 Sep; 2(11):1305-10. PubMed ID: 11018446
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages.
Castro M; Morgenthaler TI; Hoffman OA; Standing JE; Rohrbach MS; Limper AH
Am J Respir Cell Mol Biol; 1993 Jul; 9(1):73-81. PubMed ID: 8393326
[TBL] [Abstract][Full Text] [Related]
5. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
[TBL] [Abstract][Full Text] [Related]
6. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii.
Vassallo R; Kottom TJ; Standing JE; Limper AH
Am J Respir Cell Mol Biol; 2001 Aug; 25(2):203-11. PubMed ID: 11509330
[TBL] [Abstract][Full Text] [Related]
7. Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses.
Kottom TJ; Hebrink DM; Jenson PE; Marsolek PL; Wüthrich M; Wang H; Klein B; Yamasaki S; Limper AH
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):232-240. PubMed ID: 28886250
[TBL] [Abstract][Full Text] [Related]
8. Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein.
Rapaka RR; Goetzman ES; Zheng M; Vockley J; McKinley L; Kolls JK; Steele C
J Immunol; 2007 Mar; 178(6):3702-12. PubMed ID: 17339468
[TBL] [Abstract][Full Text] [Related]
9. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.
Empey KM; Hollifield M; Garvy BA
Infect Immun; 2007 Jul; 75(7):3382-93. PubMed ID: 17485459
[TBL] [Abstract][Full Text] [Related]
10. The Interaction of
Kottom TJ; Hebrink DM; Jenson PE; Nandakumar V; Wüthrich M; Wang H; Klein B; Yamasaki S; Lepenies B; Limper AH
J Immunol; 2017 May; 198(9):3515-3525. PubMed ID: 28298521
[No Abstract] [Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
Paine R; Preston AM; Wilcoxen S; Jin H; Siu BB; Morris SB; Reed JA; Ross G; Whitsett JA; Beck JM
J Immunol; 2000 Mar; 164(5):2602-9. PubMed ID: 10679099
[TBL] [Abstract][Full Text] [Related]
12. A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro.
Stehle SE; Rogers RA; Harmsen AG; Ezekowitz RA
Scand J Immunol; 2000 Aug; 52(2):131-7. PubMed ID: 10931380
[TBL] [Abstract][Full Text] [Related]
13. Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.
Zhang ZQ; Wang J; Hoy Z; Keegan A; Bhagwat S; Gigliotti F; Wright TW
Infect Immun; 2015 Dec; 83(12):4594-603. PubMed ID: 26371121
[TBL] [Abstract][Full Text] [Related]
14. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages.
Hoyte JS; Standing JE; Limper AH
Inflammation; 1997 Jun; 21(3):335-45. PubMed ID: 9246575
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis carinii induces an oxidative burst in alveolar macrophages.
Hidalgo HA; Helmke RJ; German VF; Mangos JA
Infect Immun; 1992 Jan; 60(1):1-7. PubMed ID: 1729174
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
Shellito JE; Kolls JK; Olariu R; Beck JM
J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
[TBL] [Abstract][Full Text] [Related]
17. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation.
Koziel H; Eichbaum Q; Kruskal BA; Pinkston P; Rogers RA; Armstrong MY; Richards FF; Rose RM; Ezekowitz RA
J Clin Invest; 1998 Oct; 102(7):1332-44. PubMed ID: 9769325
[TBL] [Abstract][Full Text] [Related]
18. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.
Limper AH
Semin Respir Infect; 1998 Dec; 13(4):339-47. PubMed ID: 9872631
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate.
Corsini E; Dykstra C; Craig WA; Tidwell RR; Rosenthal GJ
Immunol Lett; 1992 Dec; 34(3):303-8. PubMed ID: 1487315
[TBL] [Abstract][Full Text] [Related]
20. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.
Lasbury ME; Tang X; Durant PJ; Lee CH
Infect Immun; 2003 Sep; 71(9):4943-52. PubMed ID: 12933836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
